GSE172016 paclitaxel 2 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE172016_paclitaxel_2_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE172016_paclitaxel_2_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE172016_paclitaxel_2_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE172016_paclitaxel_2_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

H3 clustered histone 7

Gene

long intergenic non-protein coding RNA 2693

Gene

leukocyte receptor cluster member 9

Gene

high mobility group box 1 pseudogene 5

Gene

zinc finger protein 311

Gene

tripartite motif containing 15

Gene

ribonuclease P subunit p21

Gene

ASNSD1 upstream open reading frame

Gene

ANAPC1 pseudogene 2

  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    H3 clustered histone 7


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    leukocyte receptor cluster member 9


  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    zinc finger protein 311


  • Gene

    tripartite motif containing 15


  • Gene

    ribonuclease P subunit p21


  • Gene

    ASNSD1 upstream open reading frame


  • Gene

    ANAPC1 pseudogene 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.